Device Firms Struggle To Find Qualified Quality Assurance Professionals
This article was originally published in The Silver Sheet
SKILLED QUALITY ASSURANCE PROFESSIONALS who have the training necessary to help medical device manufacturers comply with FDA’s regulatory requirements are becoming hard to find despite the promise of good wages and benefits, some firms say. "Every [QA] position that we have posted, no matter what level the position, almost always seems to take us at least three months to fill," says Elisabeth George, VP of quality & regulatory at Philips Medical Systems. Now, industry is turning to colleges and universities to help fill the need for QA experts by urging schools to create new quality-related programs while strengthening existing ones. Meanwhile, CDRH Compliance Director Tim Ulatowski recommends that firms choose their QA professionals wisely and offers tips on the skills that those in quality should possess. "Within the first five minutes of meeting with a [QA] team from industry [I] get a sense of whether or not they understand their roles and responsibilities, and they understand their product," he says...
You may also be interested in...
Quality Desert: How An Academic Minor In Quality Could Be The Key To Quenching Industry's Thirst For QA Professionals
The medtech industry is facing a quickening problem of older workers retiring, leaving holes to fill in quality departments around the globe. In response, a Medical Device Innovation Consortium (MDIC) "Quality as a Career" workgroup partnered with Pathway for Patient Health to create a Quality Science Education framework that can be used by any university or college in the world free-of-charge. The program, packaged as an academic minor, includes six quality-focused courses for students to complete. Xavier University in Cincinnati, OH, recently became the first school to use the program curriculum.
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.